Results 191 to 200 of about 1,254,353 (318)

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

Molecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober, Leire Moreno‐Cugnon, Laura Martínez‐Pérez, Amaia Ercilla, Amaia Zabala‐Letona, Adrián Vicente‐Barrueco, Maider Fagoaga‐Eugui, Saioa Garcia‐Longarte, Blanca Calle‐Ciborro, Encarnación Pérez‐Andrés, Onintza Carlevaris, Sara Pozo, Isabel Mendizabal, Ugo Mayor, Arkaitz Carracedo, Violaine Sée, Edurne Berra   +16 more
wiley   +1 more source

Tracking the Complex Dynamics of Electron-Transfer-Mediated Decay in Real Space and Time. [PDF]

J Am Chem Soc
Trinter F, Hofierka J, Rist J, Kircher M, Weller M, Melzer N, Tsitsonis D, Geyer A, Kruse J, Kastirke G, Williams JB, Miteva T, Dörner R, Schöffler MS, Kunitski M, Sisourat N, Cederbaum LS, Jahnke T.   +17 more
europepmc   +1 more source

Multitemporal modeling and simulation of the complex dynamics in urban wetlands: the case of Bogota, Colombia. [PDF]

Sci Rep, 2023
Cuellar Y, Perez L.
europepmc   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

Molecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi, Stavros Makrodimitris, Sandra van Wilpe, Iris te Paske, Vanja de Weerd, Corine M. Beaufort, Hans M. Westgeest, Jens Voortman, Maureen J. B. Aarts, Maud Rijnders, Astrid A. M. van der Veldt, Ronald de Wit, Niven Mehra, Saskia M. Wilting, Debbie G. J. Robbrecht   +14 more
wiley   +1 more source

Cell stress activates γ9δ2 T cells via endogenous phosphoantigens and butyrophilin complex dynamics. [PDF]

Biomed Pharmacother
Jin Y, Nguyen K, Bashir S, Pawge G, Strand RM, Hsiao CC, Vinogradova O, Wiemer AJ.   +7 more
europepmc   +1 more source

A robust image encryption scheme based on compressed sensing and novel 7D oscillato with complex dynamics. [PDF]

Heliyon, 2023
Ndassi HL, Kengne R, Gakam Tegue AG, Motchongom MT, Tchitnga R, Tchoffo M.   +5 more
europepmc   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Sliding physical invariant neural operator for long-term prediction of complex dynamics in physical systems. [PDF]

Natl Sci Rev
Wang Y, Li Y, Peng Y, Ying S.
europepmc   +1 more source

Complex dynamics in a synchronized cell-free genetic clock. [PDF]

Nat Commun, 2022
Aufinger L, Brenner J, Simmel FC.
europepmc   +1 more source

Dynamics of complex oligosaccharides

Biophysical Journal, 1994
openaire   +2 more sources